# BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

> **NCT02836639** · PHASE2 · UNKNOWN · sponsor: **Pusan National University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Etoposide
- **DRUG:** Bendamustine

## Key facts

- **NCT ID:** NCT02836639
- **Lead sponsor:** Pusan National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2019-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836639, "BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02836639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*